Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225881 · ClinicalTrials.gov registry record · NA
Eatwell Clinical Trial (R01)
A NA study of Cancer Prevention and Dietary Guidelines, sponsored by Drexel University.
- Recruiting
- Registry status
- NA
- Development phase
- 472
- Enrollment target
- 1
- Study location
NCT07225881: Recruiting NA study of Cancer Prevention and Dietary Guidelines, sponsored by Drexel University.
NCT07225881 is a NA study of Cancer Prevention and Dietary Guidelines that is actively recruiting participants, run by Drexel University. The registered enrollment target is 472 participants, above the 344-participant average among 6 other Cancer Prevention trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225881, a NA study of Cancer Prevention and Dietary Guidelines, is actively recruiting participants, sponsored by Drexel University.
- RECRUITING
- Registry status
- NA
- Development phase
- 472 participants
- Enrollment target
- 1
- Study location
Study Summary
Cancer is a leading cause of death and will affect many people in their lifetimes. Organizations such as the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) have noted that dietary quality is a key factor influencing cancer risk, but most Americans do not meet these dietary guidelines for cancer prevention. The proposed study will enroll adults from the community (n=236 index participants, 236 household members; N = 472) who have low adherence to WCRF/AICR's four dietary guidelines. Participants will be randomized to either nutrition education or the Eatwell intervention. The Eatwell intervention content is focused on helping participants make healthier grocery shopping decisions, eat at home more often to take advantage of the optimal defaults present there, and learn how to navigate temptation when eating away from home. The findings will be relevant not only to the field of cancer prevention, but to the prevention of other diseases for which dietary quality is important.
Primary Outcome
Index participants will complete the ASA24 for 2 weekdays and 1 weekend day at each assessment point. A research assistant (blind to study condition) will complete the first food recall at baseline with each participant via videoconference. Participants complete recalls independently thereafter unless they indicate a preference for completing with a staff member. Information on dietary intake from the ASA24 will be used to calculate the total dietary adherence score, which is the primary outcome
Conditions Studied
Interventions
- BEHAVIORAL Eatwell
- OTHER Nutrition Education Control Group
Study Locations (1)
Pennsylvania
- Drexel University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 472 participants |
| Start Date | 2026-02-10 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
What NCT07225881 shows while recruiting
NCT07225881 is an interventional study that assigns participants to a tested intervention. The registered 472 participants enrollment target is mid-sized for trials with a published cap, above the 344-participant average among 6 other Cancer Prevention trials with a reported enrollment target (37% higher).
The record links to 2 conditions, with Cancer Prevention appearing as the primary indexed condition, and to 2 interventions - of which Eatwell is the first listed.
NCT07225881 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07225881 about?
NCT07225881 is a clinical study titled "Eatwell Clinical Trial (R01)". Cancer is a leading cause of death and will affect many people in their lifetimes. Organizations such as the American Cancer Society and the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) have noted that dietary quality is a key factor influencing cancer risk, but most...
What is the current status of trial NCT07225881?
This trial is currently recruiting. It is a NA study. The enrollment target is 472 participants. The study started on 2026-02-10. Estimated completion is 2030-04-30.
What conditions does trial NCT07225881 study?
This clinical trial studies the following conditions: Cancer Prevention, Dietary Guidelines.
What interventions are being tested in trial NCT07225881?
The interventions under investigation include: Eatwell (BEHAVIORAL), Nutrition Education Control Group (OTHER).
Who is sponsoring clinical trial NCT07225881?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225881 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation and Evaluation of an Evidence-Based, Multilevel Lifestyle Intervention for Underserved and Rural Populations in South Texas
RECRUITING · NA
-
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
RECRUITING · NA
-
Dietary Fiber and Time Restricted Eating
RECRUITING · NA
-
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
RECRUITING · NA
-
Using Social Networks to Promote Physical Activity in African American and Hispanic Women
ACTIVE NOT RECRUITING · NA
-
Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06375083 · 472 participants · Phase 2
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
- NCT06947187 · 472 participants · NA
Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere
- NCT07199517 · 472 participants · NA
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
- NCT03010150 · 471 participants
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI